https://european-biotechnology.net/wp-content/uploads/2025/12/FIDA-1030x481-1.png4811030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-16 09:44:182025-12-16 09:44:18Eifo and Fsg back Fida Biosystems with €5m investment
https://european-biotechnology.net/wp-content/uploads/2025/12/2019_09_03_zealand.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-12 08:28:062025-12-12 08:28:06Zealand pays Chinese OTR US$30m upfront to expand obesity pipeline
https://european-biotechnology.net/wp-content/uploads/2025/12/Eli-Lilly-Corporate-Center-Indianapolis-e1765526191927.jpg541960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-12 07:56:422025-12-12 07:56:42Lilly‘s retatrutide delivers record weight loss
https://european-biotechnology.net/wp-content/uploads/2025/12/San-Antonio-Breast-Cancer-Symposium-1030x513-1.jpg5131030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-12 06:09:302025-12-12 06:09:30Pfizer presents data for Tukysa in HER2-positive breast cancer
https://european-biotechnology.net/wp-content/uploads/2025/12/Giredestrant-structure_Pubchem-e1765533664263.png232300Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-12 05:01:162025-12-12 05:01:16Roche presents details on breast cancer pill giredestrant
